Arthrone
PrivateLast Round
Series C
Extension
Apr 3, 2026
Total Funding Raised
$49.8M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Arthrone operates in Healthcare & Life Sciences and is based in Beijing. Its latest recorded funding round was a Series C Extension round in April 2026.
Arthrone is a therapeutic devices company that develops and manufactures orthopaedic medical devices designed to restore joint function and treat musculoskeletal conditions.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Advanced Materials
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Arthrone Comparables
Compare Arthrone with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| AK Medical Holdings Ltd | 83% | |
| Just Medical Devices (Tianjin) Co., Ltd. | 83% | |
| Beijing Lidakang Technology Co., Ltd. | 82% |
For institutional investors. Book with your work email.
Arthrone Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C Extension | Apr 3, 2026 | ||||
| Series C | Aug 25, 2023 | ||||
| Series B | Mar 10, 2021 | ||||
| Series A | May 21, 2019 | ||||
| Angel | Sep 6, 2017 |
For institutional investors. Book with your work email.
Arthrone Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Beijing E-Town International Investment & Development Co., Ltd. | Series C Extension |
| Qianshan Capital Management Co., Ltd. | Series A |
| Huimei Capital | Series B |
| CDIB Capital International | Series C |
| SAIF Partners | Series C |
| Cowin Capital | Series B |
| Taihe Capital | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 3, 2026
Raised $21M led by Beijing E-Town International Investment.
- Sep 6, 2017
Completed an Angel funding round.
For institutional investors. Book with your work email.
Arthrone Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Arthrone's valuation, stock price, and market status.
Is Arthrone a public or private company?
Arthrone is a private company.
What is the current stock price of Arthrone?
Arthrone is a private company, so its shares have no public market price. Caplight tracks Arthrone's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Arthrone worth (valuation)?
Valuation information for Arthrone is not publicly available.
Can I buy Arthrone stock?
Arthrone shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Arthrone's last funding round?
Arthrone's most recent funding round was Series C Extension on April 3, 2026.
Who are the main investors in Arthrone?
Key investors in Arthrone include Beijing E-Town International Investment & Development Co., Ltd., Huimei Capital, SAIF Partners.
Will Arthrone IPO soon?
No public IPO plans have been announced for Arthrone.
How can I track Arthrone secondary market activity?
Caplight tracks bids, offers, and trades in Arthrone's shares on secondary markets.